Date recorded: October 14 2021
Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of solid form following processing?
Join our webinar to find out how Malvern Panalytical’s solution for solid form screening and validation enables better decision-making in drug development projects.
Our expert panel will discuss:
• Why solid form analysis is important during preclinical and clinical pharmaceutical development
• The requirements for an X-ray powder diffraction (XRPD) instrument to support various development stages: from preclinical scale-up to clinical Phase I (first-in-human) trials and onwards to manufacturing
• How to define CMC (Chemistry, Manufacturing, Control) strategies for regulatory submissions, such as Investigational New Drug (IND) or New Drug Application (NDA)
We will introduce Malvern Panalytical’s XRD portfolio and show how a benchtop diffractometer can deliver results quickly and simply, with all the data quality you would expect from a research laboratory diffractometer.Using real-life case studies, you’ll see how to generate the answers you need in just a few simple steps. You’ll realize that there’s no need to be an XRD expert to feel confident about solid form selection and validation in your development or manufacturing routines.